Today, biomaterial-based solutions play an important role in clinical applications.
They can be implemented e.g. astissue repair scaffolds or replace elements of damaged body parts. As these biomaterials directly interact with the human body, unforseen adverse reactions can occur.
PANBioRA will develop a tool to better assess a patient-specific immune reaction to biomaterials and thus allow improved clinical outcomes.
Share your digital solution on the eHealth Hub Platform to help to manage the healthcare crisis!
Michale Gasik from Aalto University is giving insights in the importance of considering mechanical aspects of biomaterials in order to improve the theraphy's outcome.
Many PANBioRA partners have contributed to the book Biomaterials for Organ and Tissue Regeneration: New Technologies and Future Prospects" to be published end of March.